These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18706703)

  • 1. Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.
    Theil DJ; Libbey JE; Rodriguez F; Whitton JL; Tsunoda I; Derfuss TJ; Fujinami RS
    J Neuroimmunol; 2008 Nov; 204(1-2):92-100. PubMed ID: 18706703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
    J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection with a recombinant vaccinia virus encoding myelin proteolipid protein causes suppression of chronic relapsing-remitting experimental allergic encephalomyelitis.
    Wang LY; Theil DJ; Whitton JL; Fujinami RS
    J Neuroimmunol; 1999 May; 96(2):148-57. PubMed ID: 10337913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
    Takács K; Chandler P; Altmann DM
    Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein.
    McRae BL; Kennedy MK; Tan LJ; Dal Canto MC; Picha KS; Miller SD
    J Neuroimmunol; 1992 Jun; 38(3):229-40. PubMed ID: 1376328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
    Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H
    J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
    Yu M; Johnson JM; Tuohy VK
    J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and suppression of an autoimmune disease by oligomerized T cell epitopes: enhanced in vivo potency of encephalitogenic peptides.
    Falk K; Rötzschke O; Santambrogio L; Dorf ME; Brosnan C; Strominger JL
    J Exp Med; 2000 Feb; 191(4):717-30. PubMed ID: 10684863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes.
    Vandenbark AA; Vainiene M; Ariail K; Miller SD; Offner H
    J Neurosci Res; 1996 Aug; 45(4):430-8. PubMed ID: 8872903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis.
    Kel J; Oldenampsen J; Luca M; Drijfhout JW; Koning F; Nagelkerken L
    Am J Pathol; 2007 Jan; 170(1):272-80. PubMed ID: 17200200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling immune response and demyelination using highly potent bifunctional peptide inhibitors in the suppression of experimental autoimmune encephalomyelitis.
    Kiptoo P; Büyüktimkin B; Badawi AH; Stewart J; Ridwan R; Siahaan TJ
    Clin Exp Immunol; 2013 Apr; 172(1):23-36. PubMed ID: 23480182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis.
    Bebo BF; Zelinka-Vincent E; Adamus G; Amundson D; Vandenbark AA; Offner H
    J Neuroimmunol; 1998 Apr; 84(2):122-30. PubMed ID: 9628453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naked DNA vaccination differentially modulates autoimmune responses in experimental autoimmune encephalomyelitis.
    Selmaj K; Kowal C; Walczak A; Nowicka J; Raine CS
    J Neuroimmunol; 2000 Nov; 111(1-2):34-44. PubMed ID: 11063819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis.
    Young DA; Lowe LD; Booth SS; Whitters MJ; Nicholson L; Kuchroo VK; Collins M
    J Immunol; 2000 Apr; 164(7):3563-72. PubMed ID: 10725711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.
    Xie C; Ciric B; Yu S; Zhang GX; Rostami A
    J Neuroimmunol; 2016 Feb; 291():59-69. PubMed ID: 26857496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells.
    Han D; Tian Y; Zhang M; Zhou Z; Lu J
    Gene Ther; 2007 Mar; 14(5):383-95. PubMed ID: 17066098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An epitope from Acanthamoeba castellanii that cross-react with proteolipid protein 139-151-reactive T cells induces autoimmune encephalomyelitis in SJL mice.
    Massilamany C; Steffen D; Reddy J
    J Neuroimmunol; 2010 Feb; 219(1-2):17-24. PubMed ID: 20005578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses of linear and cyclic PLP139-151 mutant peptides in SJL/J mice: peptides in their free state versus mannan conjugation.
    Katsara M; Deraos S; Tselios TV; Pietersz G; Matsoukas J; Apostolopoulos V
    Immunotherapy; 2014; 6(6):709-24. PubMed ID: 25186603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.